Morpholino PMO / Nucleoside Intermediates
7'-OH-O6-[2-(4-Nitrophenyl)ethyl]-N2-isobutyryl-N-trityl morpholino guanosine
Quick view. 7'-OH-O6-[2-(4-Nitrophenyl)ethyl]-N2-isobutyryl-N-trityl morpholino guanosine is listed for research-use inquiry under Morpholino PMO / Nucleoside Intermediates. Its identity is controlled by the retained exact structure and product-form evidence because no public CAS Registry Number is assigned. CAS N/A. Catalog target purity: Specification by inquiry. Availability: Inquiry only — contact OROGO to confirm current availability.
Request a quote Review request checklist
![Chemical structure of 7'-OH-O6-[2-(4-Nitrophenyl)ethyl]-N2-isobutyryl-N-trityl morpholino guanosine](/structures/798284a56fc389b3.svg)
Catalog status
Scope. "Available for inquiry" is not a stock claim. Operating tier is a catalog-merchandising priority. Development phase and program context are shown only where the reviewed catalog source provides a mapping; they describe the chemistry platform and do not claim that OROGO supplies the named program.
| Supply status | Available for inquiry |
|---|---|
| Operating tier | Priority |
| Reviewed supporting program count | 2 |
| Representative chemistry-platform program | viltolarsen |
| Development context | ↑ Upstream — reviewed as a supporting input; no direct development phase is assigned |
| CAS status | Not published for this exact form |
Product profile
7'-OH-O6-[2-(4-Nitrophenyl)ethyl]-N2-isobutyryl-N-trityl morpholino guanosine is classified as morpholino pmo / nucleoside intermediates (Formula C41H41N7O6; molecular weight 727.80).
7'-OH-O6-[2-(4-Nitrophenyl)ethyl]-N2-isobutyryl-N-trityl morpholino guanosine is associated with guanine-containing building blocks or substrates for G-position incorporation and analytical comparison.
For 7'-OH-O6-[2-(4-Nitrophenyl)ethyl]-N2-isobutyryl-N-trityl morpholino guanosine, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Physicochemical data
| CAS status | No public CAS assigned |
|---|---|
| Identity control | Reviewed exact name, structure, and product form |
| InChIKey | MZOWZACWEAZPAK-OIDHKYIRSA-N |
| InChI | InChI=1S/C41H41N7O6/c1-28(2)38(50)44-40-43-37-36(39(45-40)53-23-22-29-18-20-33(21-19-29)48(51)52)42-27-47(37)35-25-46(24-34(26-49)54-35)41(30-12-6-3-7-13-30,31-14-8-4-9-15-31)32-16-10-5-11-17-32/h3-21,27-28,34-35,49H,22-26H2,1-2H3,(H,43,44,45,50)/t34-,35+/m0/s1 |
| SMILES | CC(C)C(=O)NC1=NC2=C(C(=N1)OCCC3=CC=C(C=C3)[N+](=O)[O-])N=CN2[C@H]4CN(C[C@H](O4)CO)C(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7 |
| Canonical SMILES | CC(C)C(=O)NC1=NC2=C(C(=N1)OCCC3=CC=C(C=C3)[N+](=O)[O-])N=CN2[C@H]4CN(C[C@H](O4)CO)C(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7 |
| PubChem CID | 162343836 |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Related products
DMT-protected (S)-cEt-A free-hydroxyl precursor
Intermediates · CAS: 1197033-18-3
OR-INTE-0112DMT-protected (S)-cEt-5-Me-U free-hydroxyl precursor
Intermediates · CAS: 1197033-21-8
OR-INTE-0113DMT-protected (S)-cEt-5-Me-C free-hydroxyl precursor
Intermediates · CAS: 1197033-15-0
OR-INTE-0115DMT-protected (S)-cEt-G free-hydroxyl precursor
Intermediates · CAS: 945628-65-9
OR-LP-0041Maleimide NHS Ester (SMCC)
Intermediates · CAS: 64987-85-5
OR-LP-00633'-Cholesteryl-TEG CPG
Intermediates · CAS: N/A
Feature and workflow background
These publications discuss a broader chemistry feature or workflow identified from the catalog name or product family. They are background reading only, not evidence for the exact OROGO product, supplied form, lot specification, availability or performance.